What Metabolon does

Metabolon, Inc. is a privately held metabolomics solutions company founded in 2000 and headquartered in Morrisville, North Carolina. The company provides untargeted and targeted metabolomics profiling services, lipidomics, microbiome analysis, and integrated bioinformatics to biopharmaceutical companies, academic research institutions, contract research organizations, government agencies, and food and environmental researchers. Its core technology combines ultra-high-performance liquid chromatography with tandem accurate mass spectrometry (UHPLC/MS/MS) with the metabolomics industry's largest Level 1 annotated proprietary biochemical reference library, currently covering 5,400+ metabolites across 70+ biochemical pathways in a single biological sample. The company has analyzed more than 2 million samples, completed over 15,000 projects, and is cited in more than 4,000 peer-reviewed publications.

Metabolon's commercial architecture is platform-plus-services. Revenue is generated primarily through quote-based metabolomics testing services performed in ISO 9001:2015, CLIA-certified, and CAP-accredited labs, with a 45+ PhD scientific staff providing expert interpretation. In May 2026, the company expanded into a product-based model with the launch of the Metabolon Verus™ Metabolomics Profiling Kit, enabling laboratories with LC-MS capability to run standardized, reproducible metabolomics workflows in-house. Distribution is conducted through direct enterprise field sales, supported by content-driven marketing (scientific publications, webinars, conferences), with named customers including Merck, Johnson & Johnson, Kite (Gilead), Mayo Clinic, Cleveland Clinic, Johns Hopkins, the National Cancer Institute, the U.S. VA's Million Veteran Program, Genomics England, the Michael J. Fox Foundation, and the China Kadoorie Biobank.

The business has scaled through a combination of equity and debt financing, including a $25 million equity round in January 2023, a $60 million credit facility from Trinity Capital in May 2024, and additional rounds in 2025. The company employs 251–500 staff and has signaled continued expansion through large cohort partnerships, geographic expansion into Europe and Asia, and the addition of a CFO with M&A experience in early 2026.

Name

Metabolon

Legal name

Metabolon, Inc.

Website

https://metabolon.com

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

101–250 employees

Short description

Metabolon provides untargeted and targeted metabolomics profiling, lipidomics, microbiome analysis, and integrated bioinformatics to biopharmaceutical, academic, government, and foundation researchers, backed by the industry's largest Level 1 annotated metabolite reference library of 5,400+ metabolites across 70+ pathways.

Ownership category

akta.pro rank

Product category

Metabolomics Services

NAICS

Medical and Diagnostic Laboratories (6215), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734)

akta.pro primary industry

Metabolomics & Lipidomics Services (HLAGANAG)

akta.pro secondary industries

DMPK / ADME & Bioanalysis (HLAGAFAC), Laboratory Developed Tests (LDTs) & Specialized Clinical Lab Assays (HLAAALAN)

Keywords

• Metabolomics services
• Biomarker discovery
• Untargeted metabolomics
• Lipidomics panels
• Multiomics research

Headquarters

HQ city

Morrisville

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Metabolomics Testing Services: Metabolon provides laboratory testing services for metabolomics analysis. Services range from untargeted discovery metabolomics to targeted quantitative panels. Services are conducted in ISO 9001:2015 and CLIA-certified labs. Pricing is quote-based, indicating a project-based service model with customized engagement based on study requirements.
2. Metabolon Verus™ Kit Sales: Sale of the Metabolon Verus™ Metabolomics Profiling Kit, which extends centralized metabolomics capabilities directly to laboratories worldwide. This represents a product-based revenue stream that complements the service model by enabling labs to run standardized metabolomics workflows in their own environments.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels6 records

Core offering

Metabolon provides metabolomics laboratory testing and analysis services through its ISO 9001:2015 and CLIA-certified labs, anchored by the Global Discovery Panel untargeted service covering 70+ biochemical pathways and 5,400+ metabolites, complemented by targeted quantitative panels, microbiome and metagenomics services, biopharma research support, and an Integrated Bioinformatics Platform. The company also sells the Metabolon Verus™ Metabolomics Profiling Kit so laboratories with LC-MS capability can run standardized metabolomics workflows in-house.

Product overview

Metabolon is a metabolomics solutions company offering a platform-plus-services architecture. The core offerings include the Global Discovery Panel (untargeted metabolomics service covering 70+ biochemical pathways and 5,400+ metabolites), targeted metabolomics panels (including Amino Acids, Bile Acids, Free Fatty Acids, Short Chain Fatty Acids, Complex Lipids, and Sphingolipids panels), and the newly launched Metabolon Verus™ Metabolomics Profiling Kit (a standardized kit for labs to perform metabolomics in-house). The company's Integrated Bioinformatics Platform provides data analysis, visualization, biomarker discovery tools, multiomics integration, and microbiome analysis capabilities. Services are conducted in ISO 9001:2015 and CLIA-certified labs, with over 25 years of experience and more than 4,000 publications citing Metabolon data.

Differentiator

Problem solved

Functional benefit

Brands

• Metabolon Verus™: The Metabolon Verus™ Metabolomics Profiling Kit is the company's first kit designed to extend cutting-edge centralized metabolomics capabilities directly to laboratories worldwide. It provides a standardized workflow for generating reproducible metabolomics data with integrated bioinformatics tools.

Products and services

• Global Discovery Panel Untargeted metabolomics service providing broad coverage of metabolites across 70+ biochemical pathways with the highest confidence identification, designed for biopharma, academic, and government researchers pursuing biomarker discovery and mechanistic insights.
• Microbiome Panel Curated untargeted metabolomics panel screening 800+ small molecules relevant to microbiome research, supporting studies that integrate microbial community data with functional metabolic impacts.
• Targeted Metabolomics Targeted metabolomics service providing absolute quantification of 1,000+ metabolites and lipids, including specialized panels for amino acids, bile acids, free fatty acids, short chain fatty acids, complex lipids, and sphingolipids, for biopharma and academic researchers.
• Metabolon Verus™ Metabolomics Profiling Kit Physical metabolomics profiling kit that enables laboratories with LC-MS capability to run standardized, reproducible metabolomics workflows in-house, including sample preparation, quality control, automated annotation, and integrated bioinformatics interpretation.
• Microbiome Research Solution Integrated microbiome offering combining a curated metabolomics panel (800+ small molecules), six metagenomics sequencing options, and 12 bioinformatics tools for integrated analysis of microbial community information with functional metabolic impacts.
• Metagenomic Sequencing Metagenomics sequencing service offering six sequencing options to support microbiome and multiomics research, enabling analysis of microbial communities alongside metabolomics data.
• Biopharma Services End-to-end metabolomics services for biopharmaceutical customers covering target identification, biomarker discovery, growth media analysis, and pharmacokinetics to support drug discovery and development programs.

Quantifiable outcome

• 2,000,000+ samples analyzed in Metabolon's state-of-the-art research facility
• +1 more outcomes

Named customers8 records

Segments6 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Five partnerships are on record, tiered core.

• Genomics EnglandcoreStrategic or Co-development Partner · 24 June 2026Metabolon delivered a large-scale metabolomics dataset to Genomics England's 100,000 Genomes Project covering more than 7,500 participants. This marks the first time metabolomics data of this scale has been generated and delivered for integration with a major national genomic initiative. The dataset will advance rare disease research and be available to approved researchers through Genomics England's Trusted Research Environment.
• Michael J. Fox Foundation for Parkinson's ResearchcoreStrategic or Co-development Partner · 17 March 2026Metabolon partnered with the Michael J. Fox Foundation to discover biomarkers and biological pathways related to Parkinson's disease. This collaboration supports the foundation's mission to find a cure for Parkinson's disease through research using Metabolon's metabolomics platform.
• Kite (Gilead company)coreStrategic or Co-development Partner · 17 February 2026Metabolon's global metabolomics platform was used by Kite researchers to conduct the largest metabolomic analysis to date in CAR T-cell therapy. The study analyzed over 3,800 longitudinal serum, plasma, and cerebrospinal fluid samples across six clinical studies, identifying metabolic signatures that associate with severe neurological events.
• Million Veteran Program (U.S. Department of Veterans Affairs)coreStrategic or Co-development Partner · 4 November 2025Metabolon supported the Million Veteran Program's 62,000-sample dataset, providing biomarker analysis as part of a large multiomics research effort. This initiative explores health factors affecting veterans, offering insights applicable to broader public health and medical research.
• China Kadoorie Biobank (CKB)coreStrategic or Co-development Partner · 9 September 2025Metabolon partnered with the China Kadoorie Biobank to profile plasma metabolomics biomarkers using its Global Discovery Panel. The study initially covers 4,000 samples linked to other multiomics data and examines how lifestyle, environmental, genetic, and socioeconomic factors influence common diseases in underrepresented populations.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Human Metabolome Technologies (HMT): Japanese metabolomics services company offering CE-MS and LC-MS based untargeted metabolomics profiling. Closely comparable business model and customer base to Metabolon, though smaller scale and Asia-Pacific anchored.
• Biocrates Life Sciences: Austria-based metabolomics company offering both targeted metabolomics services and standardized kits/panels (e.g., MxP® Quant 500). Direct competitor in both service and kit-based metabolomics, particularly in European biopharma.
• Chenomx: Canadian metabolomics company offering NMR-based profiling services and proprietary software for metabolite identification. Comparable in offering metabolomics analysis with proprietary reference libraries, though uses NMR rather than LC-MS/MS.
• Metabolomic Discoveries: German metabolomics services company (now part of Metabolon following 2017 acquisition, though operating semi-independently). Direct comparable in targeted and untargeted metabolomics services for pharma and academic research.

Broad incumbents

• Bruker Corporation: Major mass spectrometry and NMR instrument vendor whose platforms underpin much of the metabolomics market. Relevant because Bruker also offers metabolomics software and increasingly service-style offerings, competing with Metabolon's workflows at the infrastructure layer.
• Waters Corporation: Leading LC-MS instrument manufacturer whose ACQUITY UPLC and Xevo MS systems are widely used for metabolomics. Competes indirectly as instrument vendors increasingly bundle bioinformatics and standardized workflows that challenge centralized services.
• Thermo Fisher Scientific: Dominant life sciences instrumentation and services conglomerate offering mass spectrometers, software, and contract lab services through PPD. Competes across the full stack Metabolon touches, with substantially greater scale and breadth.
• Eurofins Scientific: Global contract laboratory services provider with extensive clinical, pharma, and metabolomics-adjacent testing capabilities. Provides large-scale lab services infrastructure that competes for outsourced research testing budgets.

Emerging players

• Olink Holding: Proteomics biomarker discovery platform with PEA technology serving biopharma and academic researchers. Comparable in being a specialty omics platform vendor pursuing multiomics integration, though focused on proteomics rather than metabolomics.

Others

• Standard BioTools (formerly Fluidigm): Life sciences tools provider offering mass cytometry and multiomics instrumentation. Adjacent in serving the multiomics research market with enabling instrumentation, though not directly competing in metabolomics services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCXc4CwryGeEE_kM-z5XZ9_A
• Facebookfacebook.com/Metabolon
• Instagraminstagram.com/metabolon
• Xx.com/Metabolon
• LinkedInlinkedin.com/company/metabolon

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds17 records

Investors16 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Metabolon